Denosumab or oral bisphosphonates in primary osteoporosis: a “real-life” study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Denosumab or oral bisphosphonates in primary osteoporosis: a “real-life” study
Authors
Keywords
Denosumab, Oral bisphosphonates, Fragility fractures, Bone mineral density
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 41, Issue 8, Pages 1005-1013
Publisher
Springer Nature
Online
2018-01-16
DOI
10.1007/s40618-018-0829-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence with denosumab therapy in women affected by osteoporosis with fragility fractures: a multicenter observational real practice study in Italy
- (2017) S. Migliaccio et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- Treatment needs and current options for postmenopausal osteoporosis
- (2016) Luigi Gennari et al. EXPERT OPINION ON PHARMACOTHERAPY
- Denosumab compared to other treatments to prevent or treat osteoporosis in individuals at risk of fracture: a systematic review and meta-analysis
- (2016) C. Beaudoin et al. OSTEOPOROSIS INTERNATIONAL
- Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis
- (2016) F. Vescini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Osteoporosis treatment: complexities and challenges
- (2016) R. A. Adler JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls
- (2016) P. Wanby et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonates for the prevention and treatment of osteoporosis
- (2015) Spyridoula Maraka et al. BMJ-British Medical Journal
- Bisphosphonates for the prevention and treatment of osteoporosis
- (2015) Spyridoula Maraka et al. BMJ-British Medical Journal
- Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
- (2014) J. P. Brown et al. OSTEOPOROSIS INTERNATIONAL
- Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis
- (2014) E. Cairoli et al. OSTEOPOROSIS INTERNATIONAL
- Treatment of post-menopausal osteoporosis: beyond bisphosphonates
- (2014) S. Ishtiaq et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
- (2013) C. Roux et al. BONE
- Prevalence of subclinical contributors to low bone mineral density and/or fragility fracture
- (2013) Cristina Eller-Vainicher et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone turnover markers: use in osteoporosis
- (2012) Kim Naylor et al. Nature Reviews Rheumatology
- Treatment failure in osteoporosis
- (2012) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
- (2012) N. Freemantle et al. OSTEOPOROSIS INTERNATIONAL
- Risk factors for prediction of inadequate response to antiresorptives
- (2011) Adolfo Díez-Pérez et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
- (2009) John P. Bilezikian AMERICAN JOURNAL OF MEDICINE
- How should we define light or intermittent smoking? Does it matter?
- (2009) C. G. Husten NICOTINE & TOBACCO RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started